The INSTITUT Study Tuberculosis Nutritional Support
INSTITUT
Impact of Nutritional Support for Tuberculosis on Intermediate and Terminal Undernutrition and Treatment Outcomes: the INSTITUT Study
1 other identifier
observational
769
2 countries
2
Brief Summary
Undernutrition is a leading global risk factor of tuberculosis (TB) and a prevalent comorbidity associated with TB. In Benin, the National TB Program systematically provides nutritional support to all persons with TB (PWTB), distributing prepared foods to hospitalized patients and food baskets during outpatient care. In Togo, the PWTB population is similar to that of Benin; however, Togo does not have a systematic program in place to provide nutritional support to these patients. The investigators will perform a prospective cohort analysis using anonymized TB patient data from the National TB Programs of Benin and Togo. Participants enrolled in Benin will receive nutritional support from the hospital while those enrolled in Togo will not. Participants in Togo who do not receive nutritional support will serve as a control. Unfavorable outcomes in both groups such as treatment failure, death, or relapse will be compared. The results from this study should help to shape TB programs in the future by incorporating nutritional support.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2023
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 7, 2023
CompletedFirst Submitted
Initial submission to the registry
October 5, 2023
CompletedFirst Posted
Study publicly available on registry
October 16, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 21, 2025
CompletedNovember 17, 2025
November 1, 2025
2 years
October 5, 2023
November 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percent of participants with an unfavorable outcome
An unfavorable outcome will be a composite of TB treatment failure, death, or relapse based on patient evaluation 6 months after treatment completion.
12 months
Secondary Outcomes (1)
Number of participants with failure of sputum conversion
2 months
Other Outcomes (1)
Number of participants lost to follow up during therapy
6 months
Study Arms (2)
Nutritional support group
Participants in this group will be enrolled in Benin and will receive nutritional support from the hospital where they receive care. They will be followed for 12 months.
Standard of care group
Participants in this group will be enrolled in Togo and will not receive nutritional support from the hospital where they receive care. They will be followed for 12 months.
Interventions
The hospitals in Benin already provide nutritional support for patients with pulmonary TB which will continue throughout the study.
Eligibility Criteria
1050 participants will be enrolled and followed for approximately 12 months. 700 will be enrolled in Benin and 350 in Togo. Participants enrolled in Benin will receive nutritional support from the hospital while those enrolled in Togo will not.
You may qualify if:
- Drug susceptible, Xpert \[polymerase chain reaction (PCR) test for TB\] positive and/or sputum stain positive for AFB (≥1+)
- Willing to attend follow-up visits and undergo study procedures
You may not qualify if:
- Drug resistant TB
- Has received 7 or more days of antimicrobial therapy
- Based on study staff observation, the participant is too sick to enroll. Defined as a score of 4 on the World Health Organization (WHO) Performance assessment.
- Pregnancy at the time of enrollment
- Individuals who are unable to participate in the 6-minute walk test due to pre-existing mobility issues due to disability, trauma, neurological compromise, or cardiopulmonary issues
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Centre Hospitalier et Universitaire de Pneumo-phtisiologie
Porto-Novo, Benin
National Tuberculosis Programme
Lomé, Togo
Related Publications (1)
Cintron C, Dauphinais M, Fiogbe AA, Dogo MF, Ate S, Adjonou C, Agossou K, Pan SJ, Esse M, Ade B, Adjoh KS, Affolabi D, Sinha P, Koura KG. Impact of Nutritional Support for Tuberculosis on Intermediate and Terminal Undernutrition and Treatment Outcomes (INSTITUT) study: a protocol for a quasi-experimental study to assess the impact of nutritional support on tuberculosis treatment outcomes in Benin and Togo. BMJ Open. 2025 Feb 10;15(2):e088629. doi: 10.1136/bmjopen-2024-088629.
PMID: 39929516DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pranay Sinha, MD
Boston Medical Center
- STUDY DIRECTOR
Kobto G Khoura, MD, PhD
The International Union Against Tuberculosis and Lung Disease
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 5, 2023
First Posted
October 16, 2023
Study Start
September 7, 2023
Primary Completion
September 10, 2025
Study Completion
September 21, 2025
Last Updated
November 17, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share